Pfizer (PFE) closed at $26.14 in the latest trading session, marking a +2.11% move from the prior day. This move outpaced the S&P 500's daily gain of 1.75%. Elsewhere, the Dow gained 1.86%, while the ...

Pfizer (NYSE:PFE | PFE Price Prediction) is in the middle of its biggest reinvention in a generation, leaning on the Seagen ...

At $25.60, Pfizer (NYSE:PFE | PFE Price Prediction) sits in Hold territory on Wall Street’s consensus. The headline 6.7% ...

BRUSSELS, June 11 () - An adviser to Europe's top court on Thursday recommended it to dismiss an appeal lodged by the ...

Pfizer stock may not be cheap enough to buy yet, but it's certainly too cheap to sell.

A legal adviser to the bloc's top court recommended rejecting key government arguments for keeping parts of the pandemic ...

One company posts rapid revenue growth but remains unprofitable, while the other boasts global scale and steady cash flow.

BRUSSELS, June 11 () - The European Commission's appeal against a 2024 ruling forcing it to disclose information about ...

Novo Nordisk received UK approval for its oral weight-loss drug as the Danish drugmaker seeks to regain lost ground in a ...

The European Commission's alleged lack of transparency in purchasing Covid-19 vaccines at the height of the pandemic is back ...

Drug companies are racing to catch up to Eli Lilly and Novo Nordisk, seeking to require fewer shots or reduce side effects.